Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-060694
Filing Date
2022-12-12
Accepted
2022-12-12 16:25:33
Documents
2
Period of Report
2022-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5681
2 EX-24 DOCUMENT attachment1.htm EX-24 4530
  Complete submission text file 0001209191-22-060694.txt   11712
Mailing Address C/O BLCO 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
PAPA JOSEPH C (Reporting) CIK: 0001242215 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 221457409

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)